OTTAWA, ON, May 23, 2025 /CNW/ -. Summary. Product: Sivem ezetimibe 10 mg tablets Issue: Health products – Product safety What to do: If your bottle of ezetimibe 10 mg tablets contains any ...

During its clinical development, a wide range of doses of ezetimibe were evaluated, from 0.625 mg to 40 mg; 5 mg lowered LDL-C significantly, albeit to a slightly lesser degree than 10 mg in some ...

Combination therapy with ezetimibe (10 mg) and statins (10–80 mg) compared with statin monotherapy also generally resulted in nonsignificant differences in the incidences of laboratory (elevated ...

The first completed Phase III study, entitled ODYSSEY MONO, tested the new lower 75-mg dose of alirocumab sc. Q2W as a monotherapy versus ezetimibe 10 mg per os (po.) every day (q.d.) as a control ...

NewAmsterdam Pharma N.V.-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each of placebo, ezetimibe 10 mg, and ...

TANDEM will support global regulatory filings for the 10 mg obicetrapib and 10 mg ezetimibe fixed-dose combination in adult patients with heterozygous familial hypercholesterolemia (“HeFH ...

The phase 3 TANDEM clinical trial (NCT06005597) was designed to evaluate 10 mg Obicetrapib and 10 mg Ezetimibe fixed-dose combination in adult patients with HeFH and/or ASCVD or multiple ASCVD ...

What to do: If your bottle of ezetimibe 10 mg tablets contains any perindopril 4 mg tablets, or if you are unsure, return it to your pharmacy immediately. If you are unable to return your tablets to ...

-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each of placebo, ezetimibe 10 mg, and obicetrapib 10 mg monotherapy at ...